Euroscreen S.A.

In addition of his own staff, in order to maximize its performance, Euroscreen choose to access to specific scientific expertise, know-how, and extensive industry experience, from experts such as:

Terry J. Opgenorth, PhD, as Drug Discovery & Pre-Clinical Development Expert; Dr. Opgenorth has 20 years of experience with Abbott ultimately serving as Divisonal Vice President of Antiviral Research, Metabolic Disease Research, and Target-Lead Discovery and responsible for the advancement of numerous projects into clinical development. 

Marc Parmentier, MD, PhD, as GPCR Expert; Dr. Parmentier is a co-founder of Euroscreen  and a full professor at the Institute of Multi-disciplinary Research in Human and Molecular Biology (I.R.I.B.H.M.) of the free University of Brussels.

Daniel F. Veber, PhD, Drug Discovery & Medicinal Chemistry Consultant.  Dan has had a four-decade long, ditinguished career in medicinal chemistry and peptide synthesis at GlaxoSmithKline (formerly SmithKline Beecham) and Merck, most recently serving as Senior Director of Medicinal Chemistry.